Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
Top Cited Papers
- 1 May 2006
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 7 (5), 392-401
- https://doi.org/10.1016/s1470-2045(06)70665-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trialJournal of Neurosurgery, 2006
- 483 ORAL Impact of extent of resection on overall survival in newly-diagnosed glioblastoma after chemo-irradiation with temozolomide: further analysis of EORTC study 26981European Journal of Cancer Supplements, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005
- A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survivalJournal of Neurosurgery, 2001
- Quantitative Imaging Study of Extent of Surgical Resection and Prognosis of Malignant AstrocytomasNeurosurgery, 1997
- Radiation response and survival time in patients with glioblastoma multiformeJournal of Neurosurgery, 1996
- Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study.Gut, 1995
- Early Postoperative Magnetic Resonance Imaging after Resection of Malignant GliomaNeurosurgery, 1994
- Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive radiation therapy oncology group (RTOG) clinical trialsInternational Journal of Radiation Oncology*Biology*Physics, 1993
- The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients.Journal of Neurology, Neurosurgery & Psychiatry, 1990